LDHA and neoplasm: Over a decade, the association between high ALDH activity and the cancer stem cell (CSC) phenotype has inspired scientists to develop specific ALDH inhibitors with greater clinical potential to effectively suppress CSCs and tumour progression (Jackson et al., 2011).